Results 21 to 30 of about 26,622 (265)

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

Journal for ImmunoTherapy of Cancer, 2021
Background Peritoneal carcinomatosis is a fatal clinical presentation of colon cancer, characterized by unresponsiveness to conventional anticancer therapies, including immune checkpoint inhibitors.
Jeong Hun Kim, Yu Seong Lee, Won Suk Lee, Seung Joon Lee, Hannah Yang, So Jung Kong, Beodeul Kang, Woo Ram Kim, Hong Jae Chon, Chan Kim, Hye Jin Lee, Jaekyung Cheon   +11 more
doaj   +1 more source

Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. [PDF]

, 2018
Peritoneal metastasis (PM) is an advanced stage malignancy largely refractory to modern therapy. Intraperitoneal (IP) immunotherapy offers a novel approach for the control of regional disease of the peritoneal cavity by breaking immune tolerance.
Bowne, Wilbur B., Katz, Steven C., Khalili, Marian, Morano, William F., Richard, Scott D., Thadi, Anusha   +5 more
core   +2 more sources

Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy

The Scientific World Journal, 2013
Background. Prolonged survival of patients affected by peritoneal metastasis (PM) of colorectal origin treated with complete cytoreduction followed by intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) has been reported. However, two-thirds
Yutaka Yonemura, Emel Canbay, Haruaki Ishibashi   +2 more
doaj   +1 more source

Pretreatment CT differential diagnosis of tuberculous peritonitis from peritoneal carcinomatosis of advanced epithelial ovarian cancer

Scientific Reports, 2023
Delayed diagnosis of female genital tuberculosis (FGTB) can lead to inappropriate treatment and unnecessary surgical procedures rather than standard anti-TB medication.
Chul-min Lee, Joong Sub Choi, Mimi Kim, Bo-Kyeong Kang, Jaeman Bae, Won Moo Lee, Un Suk Jung, Jeong Min Eom, Yeon Kyoung Kim, Jin Young Kim   +9 more
doaj   +1 more source

Risk factors associated with peritoneal carcinomatosis of gastric cancer in staging laparoscopy: A systematic review and meta-analysis

Frontiers in Oncology, 2022
BackgroundThe optimal indications of staging laparoscopy in gastric cancer to detect peritoneal carcinomatosis are still controversial. We performed this systematic review and meta-analysis to quantify the relevance of the preoperative factors with ...
Guangmin Guan, Zhemin Li, Qi Wang, Xiangji Ying, Fei Shan, Ziyu Li   +5 more
doaj   +1 more source

Peritoneal carcinomatosis

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2011
Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is now an established therapy with a curative option for patients with gastrointestinal and gynecological peritoneal carcinomatosis as well as for primary peritoneal carcinomatous tumors.
I, Königsrainer, S, Beckert, T, Lehmann, R, Ladurner, B, Brücher, A, Königsrainer   +5 more
  +5 more sources

Dynamic assessment of intraperitoneal aerosol chemotherapy under pressure impact on peritoneal carcinomatosis in ovarian cancer (immediate results)

Южно-Российский онкологический журнал, 2023
Purpose of the study. Dynamic assessment of the direct impact of pressurized intraperitoneal aerosol chemotherapy (PIPAC) on peritoneal carcinomatosis in ovarian cancer.Patients and methods.
A. S. Dzasokhov, A. A. Kostin, V. L. Astashov, M. A. Andreev, A. V. Turiev, A. D. Uskov   +5 more
doaj   +1 more source

Peritoneal Dissemination of Hepatoid Carcinoma of the Ovary Treated with Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy

Case Reports in Medicine, 2013
Hepatoid carcinoma of the ovary (HCO) was first reported in 1987 in 5 cases of malignant ovarian tumors which were similar to hepatocarcinoma in the histological analysis. We report the first case in the literature of a patient diagnosed with HCO treated
Pedro Antonio Cascales Campos, Jose Gil Martinez, Amparo Torroba, Francisco Machado, Pascual Parrila Paricio   +4 more
doaj   +1 more source

Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases

Trials, 2010
Background The standard of care for colorectal peritoneal carcinomatosis is evolving from chemotherapy to cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with disease limited to the peritoneum.
Steinberg Seth M, Kemp Clinton D, Davis Jeremy L, Ripley Robert T, Toomey Mary, Avital Itzhak   +5 more
doaj   +1 more source

Identifying the source of peritoneal carcinomatosis by molecular biological method (a clinical case) [PDF]

РМЖ. Мать и дитя, 2023
K.R. Ishmuratova1,2 1Bashkir State Medical University, Ufa, Russian Federation 2Republican Clinical Oncological Dispensary, Ufa, Russian Federation In recent decades, multiple biological markers have been discovered which demonstrate a high ...
K.R. Ishmuratova
doaj